Search for Clinical Trial Results

Sponsored By

Osteoporosis, Postmenopausal - 26 Studies Found

Status Study
Completed Study Name: Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan
Condition: Osteoporosis, Postmenopausal
Date: 2011-07-19
Interventions: Drug: E2 transdermal (Julina, BAY86-5435) Patients in daily life treatment receiving Julina for postmeno
Completed Study Name: Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment
Condition: Osteoporosis, Postmenopausal
Date: 2010-06-03
Interventions: Other: OPSAT-Q A linguistically validated Korean version of OPSAT-Q
Completed Study Name: 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
Condition: Osteoporosis, Postmenopausal
Date: 2005-09-12
Interventions:
  • Drug: Teriparatide
  • Drug: Raloxifene
Completed Study Name: Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)
Condition: Osteoporosis, Postmenopausal
Date: 2006-01-03
Interventions:
  • Drug: ibandronate, calcium and vitamin D

Completed Study Name: Julina Post-marketing Surveillance for Climacteric Symptoms in Japan
Condition: Osteoporosis, Postmenopausal
Date: 2011-06-16
Interventions: Drug: E2 transdermal (Julina, BAY86-5435) Patients in daily life treatment receiving Julina for postmeno
Completed Study Name: Study With AMG 785 to Treat Japanese Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis (PMO)
Date: 2013-11-19
Interventions:
  • Drug: AMG 785 AMG 785 subcutan
Completed Study Name: Risedronate Sodium in Post Menopausal Osteoporosis
Condition: Osteoporosis, Postmenopausal
Date: 2007-03-28
Interventions: Drug: risedronate sodium
Completed Study Name: Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Date: 2007-09-18
Interventions: Drug: Teriparatide Teriparatide 20 micrograms/daily subcutaneously
Completed Study Name: Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical Practice
Condition: Osteoporosis, Postmenopausal
Date: 2012-07-26
Interventions: Biological: Denosumab This is an non-interventional study, therefore denosumab is administered as part o
Completed Study Name: Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan
Condition: Postmenopausal Osteoporosis
Date: 2015-04-16
Next >>>